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Abstract 
Background: Understanding the risk factors associated with hospital burden of COVID-19 is crucial for healthcare 
planning for any future waves of infection.
Methods: An observational cohort study is performed, using data on all PCR-confirmed cases of COVID-19 in 
Regione Lombardia, Italy, during the first wave of infection from February-June 2020. A multi-state modelling 
approach is used to simultaneously estimate risks of progression through hospital to final outcomes of either death 
or discharge, by pathway (via critical care or not) and the times to final events (lengths of stay). Logistic and time-
to-event regressions are used to quantify the association of patient and population characteristics with the risks of 
hospital outcomes and lengths of stay respectively.
Results: Risks of severe outcomes such as ICU admission and mortality have decreased with month of admission (for 
example, the odds ratio of ICU admission in June vs March is 0.247 [0.120–0.508]) and increased with age (odds ratio 
of ICU admission in 45–65 vs 65 + age group is 0.286 [0.201–0.406]). Care home residents aged 65 + are associated 
with increased risk of hospital mortality and decreased risk of ICU admission. Being a healthcare worker appears to 
have a protective association with mortality risk (odds ratio of ICU mortality is 0.254 [0.143–0.453] relative to non-
healthcare workers) and length of stay. Lengths of stay decrease with month of admission for survivors, but do not 
appear to vary with month for non-survivors.
Conclusions: Improvements in clinical knowledge, treatment, patient and hospital management and public health 
surveillance, together with the waning of the first wave after the first lockdown, are hypothesised to have contributed 
to the reduced risks and lengths of stay over time.
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Background
Since the start of the coronavirus disease 2019 (COVID-
19) pandemic, understanding the severe burden on 
healthcare, particularly hospitals, and the risk factors 
associated with severe events has been a crucial ques-
tion. Note that by “risk factors” we mean covariates sig-
nificantly associated with the outcome. Initial research 
[1–4] demonstrates that older age (> 60), male sex and 
having pre-existing medical conditions (comorbidities) 
are risk factors associated  with severe events in hospi-
talized COVID-19 patients, such as intensive care unit 
(ICU) admission, intubation and mortality. However, 
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much of this early work used standard survival analysis, 
without accounting for the competing risks of different 
pathways through hospital (e.g. death without ICU vs 
ICU vs recovery without ICU; or death in ICU vs recov-
ery & transfer to a post-ICU ward). Ignoring competing 
outcomes can bias estimates of risks such as the hospital-
fatality risk—the probability that a hospital admission for 
COVID-19 disease can lead to death—and therefore of 
effect sizes [5]. While analyses accounting for competing 
events have been performed in other countries [6, 7], to 
our knowledge, only standard survival analysis has been 
used for data collected in Italy. We therefore present a 
comprehensive study of risk factors associated with pro-
gression through hospital to either discharge or death, via 
ICU or not, while accounting for competing risks.
The first Italian individual confirmed positive for the 
novel SARS-CoV-2 virus was identified on 20th February 
2020 in Codogno, Regione Lombardia. Confirmed cases 
of COVID-19 rapidly increased to 403 in just one week 
[8], peaking on 20th March 2020 and causing a pressure 
build-up on the regional healthcare system. Efforts were 
directed to expanding the number of beds, especially in 
ICU [9]. Using a “hub-and-spoke” model [10], suspected 
COVID-19 patients were admitted to one of 17 desig-
nated hub hospitals in the Infectious Disease Hospital 
Network, chosen due to their skill in the fields of infec-
tious disease and intensive care. In Lombardy a substan-
tial proportion of patients were treated in hospital rather 
than at home [11] and treatment changed according to 
the severity of symptoms: no treatment was suggested 
for asymptomatic or mildly symptomatic patients with 
no comorbidities; therapy for symptoms and oxygen sup-
port were indicated for at-risk-of-progression patients 
with mild symptoms or with moderate symptoms; while 
critically ill patients were referred to ICU [12]. During 
the first wave, the highest number of patients admitted 
to hospital per day was reached in mid-March, with 838 
patients, of whom 56 were admitted to ICU [13]. In addi-
tion to the “hub-and-spoke” model implemented, the 
Prevention Unit of the General Directorate of Welfare 
of Regione Lombardia coordinated data collection from 
laboratories and healthcare on all confirmed cases of 
COVID-19 into a single id-hinged register, the COVID-
19 Regional Database [14].
The aims of this study are to assess: the magnitude of 
the burden of the COVID-19 pandemic on Lombardia 
secondary healthcare in terms of risks of severe out-
comes and lengths of stay in hospital; and how this bur-
den varies across demographic and health groups. Use 
of the subset of cases in the COVID-19 Regional Data-
base who were hospitalised allows quantification of 
the within-hospital burden using a multi-state model-
ling approach [15] to account for competing risks. We 
simultaneously estimate the risks of each possible path-
way through hospital (with or without ICU admission, to 
either discharge or death) and the times taken to reach 
each outcome (lengths of stay both overall and in differ-
ent wards: pre-ICU, ICU and post-ICU). Detailed patient 
information allows assessment of the risk factors associ-
ated with progression through hospital and outcomes. 
Crucially, we assess not only patient characteristics such 
as age and sex, but also population-level risk factors: (i) 
month of admission, as a proxy for the external state and 
public health management of the epidemic and changes 
in clinical treatment and hospital management of cases; 
and (ii) hospital size, as a proxy for Regione Lombardia’s 
use of the “hub-and-spoke” model.
Methods
Study participants
The Lombardia COVID-19 Regional Database, as of 5th 
August 2020 and covering the period 1st December 2019 
to 17th July 2020, contains detailed pseudo-anonymised 
retrospective individual-level data on the cohort of 
all individuals in Regione Lombardia diagnosed with 
COVID-19 via polymerase chain reaction (PCR) during 
the first wave. This dataset is described in full elsewhere 
[10, 14] (see also Additional file  1: Appendix S1), but 
briefly, records age, sex, Local Healthcare Agency district 
of Lombardia, presence of co-morbidities, whether the 
individual is a healthcare worker or care home resident, 
presence of symptoms, whether or not the individual 
was hospitalised, and if so, details of the admitting hos-
pital. For each individual, dates of symptom onset, posi-
tive laboratory test, hospital admission, ICU admission, 
ICU discharge, hospital discharge, recovery and death 
are recorded. Here the subset of 40,550 patients who 
were admitted to hospital between February and June, 
with known admission date and admitting hospital, and 
who had consistent date information are analysed (Addi-
tional file 1: Appendix S1, Figure S1). Seven key covari-
ates describing patient and hospital characteristics are 
considered to understand risk factors associated with 
progression through hospital. In order of hypothesised 
importance, these are: age group (0–45, 46–65, 66 +); sex 
(male, female); month of admission (Feb, Mar, Apr, May, 
Jun); presence of at least one co-morbidity (defined as a 
pre-existing medical condition and categorised as res-
piratory, cardio-vascular, metabolic or oncological, see 
Additional file 1: Appendix S1); care home resident (yes, 
no); healthcare worker (yes, no); and hospital bed capac-
ity (large, medium or small, defined according to the 
numbers of hospital and ICU beds, see Additional file 1: 
Appendix S1, Table S1). All methods detailed below were 
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performed in accordance with the relevant guidelines 
and regulations governing these data.
Multi‑state model
As in Grosso, Presanis et  al. (2021) [10], the progres-
sion of patients through hospital can be represented by 
a multi-state model with states Hospital, ICU, Post-ICU, 
Discharge, and Death (Fig.  1). The outcomes of inter-
est are: the probabilities of entering each state (a “next 
event”) given the current state; the probabilities of final 
events, either Death (“hospital-fatality risk”, as defined in 
Additional file 1: Appendix S4) or Discharge, given hos-
pital admission or the current state; and corresponding 
times to each next event, conditional on experiencing the 
next event, i.e. the lengths of stay (LoS) in each state; and 
the total LoS in hospital.
The type of multi-state model considered is a “mix-
ture model” [15, 16], combining multinomial or binomial 
logistic regression of probabilities of different pathways 
through hospital on covariates with parametric time-to-
event analyses for each LoS in a state, conditional on the 
next event occurring.
In the dataset considered, outcomes are missing 
for < 1% of individuals in the Hospital and ICU states, 
and for 15% of individuals in the Post-ICU state. It is 
unknown whether the missing outcomes had not hap-
pened by the end-date of the data, 17th July, ("right-cen-
soring"), or whether the outcome had happened, but was 
not recorded ("missing data/loss to follow-up"). Grosso, 
Presanis et  al. [10] considered two alternative assump-
tions for the Lombardia dataset, since it is impossible to 
distinguish between censoring and missing outcomes: (1) 
the missing outcomes are ignorable; (2) these individu-
als are right-censored at one day after their last observed 
event. The results are very similar under the two assump-
tions, so in what follows, the results under assumption 
(1) are reported for models with multiple covariates, 
since computation for multivariable models is more fea-
sible under assumption (1). This computation is feasible 
because by ignoring missing outcomes, the multi-state 
model can be split into its component parts and imple-
mented in a modular way: the logistic regression models 
for the probabilities; and the parametric time-to-event 
models.
The factorised models are fitted using a covariate selec-
tion procedure, as detailed in the following sections. 
Point estimates and 95% confidence intervals (CIs) are 
reported for each probability of interest, as well as for 
the median and interquartile ranges (IQRs) of each time-
to-event distribution. The confidence intervals represent 
parameter uncertainty, whereas the median and IQRs 
summarise the heterogeneity across individuals in the 
time-to-event distributions.
All analyses were carried out in R version 3.6.3, using 
the flexsurv package [15].
Probabilities of next events
Multinomial logistic regression is carried out for the 
transition probabilities from hospital admission to the 
next events (discharge, ICU admission, death without 
ICU admission). Binomial logistic regression is employed 
for the transition probabilities: from ICU to post-ICU or 
death; and from a post-ICU stay to discharge or death.
Multivariable models with main effects only are first 
considered, adding covariates one at a time, in order of 
hypothesised importance. The model that minimises 
Akaike’s Information Criterion (AIC) is selected. To 
Fig. 1 Multi-state model
Table 1 Covariate summaries
Covariate Level Number Proportion 
(%)
Age group [0,45] 4236 10.45
(45,65] 13,010 32.08
(65,Inf ] 23,304 57.47
Sex Female 16,063 39.61
Male 24,487 60.39





At least 1 co-morbidity? No 14,787 36.47
Yes 25,763 63.53
Care home resident? No 38,825 95.75
Yes 1725 4.25
Healthcare worker? No 38,889 95.90
Yes 1661 4.10
Hospital bed capacity Large 28,663 70.69
Medium 5288 13.04
Small 6599 16.27
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investigate interactions, four additional models are con-
sidered, based on what interactions are expected to be 
important: (a) age group interacting with the covariates 
selected at the previous step; (b) month of admission 
interacting with the covariates selected at the previ-
ous step; (c) age group interacting with all other covari-
ates; (d) month of admission interacting with all other 
covariates. The final model is chosen among the interim 
selected model without interactions and the interaction 
models (a)-(d) as the one that minimises the AIC.
Times to next events
Conditional on patients experiencing each next event, 
parametric models are fit independently for each time 
from a hospital admission, ICU admission or post-
ICU state to the next event (i.e. each LoS). A two-step 
procedure is used to select a model for each transition, 
where first covariates (as above), then parametric dis-
tributions (generalised gamma, gamma, log-normal or 




Covariate summaries for the 40,550 patients in the Lom-
bardia hospital cohort are shown in Table 1. Patients in 
this cohort had a median age of 69 (interquartile range 
[56–80]), with the youngest aged 0 and the oldest aged 
102.
Figure  2 displays, by age group, the empirical distri-
butions of the times between events, namely LoS in the 
Hospital, ICU and Post-ICU states, by subsequent events.
Fig. 2 Observed distributions of lengths of stay: times from starting states (hospital admission, ICU admission, post-ICU stay: rows) to next events 
(ICU admission, a post-ICU stay, discharge and death: columns), by age group (colours, y-axis). Vertical scale proportional to number of individuals
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Month of admission trends by age and sex
The selected models for the transition probabilities 
and times-to-next-events (distributions and covariates 
selected) are summarised in Additional file 1: Tables S2 
and S6. Covariate effects in terms of odds ratios (ORs) 
and expected time ratios (ETRs) are fully reported in 
Additional files 1: S2 and S3.
For most of the selected models for either the prob-
abilities of or times to next events, age was an important 
covariate, whereas sex, if significant, had only small effect 
Fig. 3 Predicted probabilities (95% confidence intervals) of moving from a hospital to next events; b ICU to next events; c a post-ICU stay to next 
events; by age, sex and month of admission. All other covariates are at their baseline if they are included in the selected model, i.e. patients in the 
largest capacity hospitals, without co-morbidities, who are neither care home residents nor healthcare workers
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Fig. 4 Estimated hospital fatality-risk by age, sex and month of admission, for patients in the largest capacity hospitals, without co-morbidities, who 
are neither care home residents nor healthcare workers
Fig. 5 Summaries of distributions of time from admission to a hospital ward to next events
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sizes. All results in this section concern patients with 
no co-morbidities in the largest capacity hospitals, who 
are neither care home residents nor healthcare workers. 
The probability of ICU admission was larger in men than 
women and in the two older age groups than the young-
est; and reduced with month of admission (ORs April 
0.644 95% confidence interval [0.553–0.750]; May 0.230 
[0.143–0.372]; and June 0.247 [0.120–0.5080] relative to 
March), see Fig.  3(a)). The probability of death without 
ICU admission was much larger in those aged 65 + than 
those younger, falling from a peak of around 30% in 
March to 10% or less in June (Fig. 3a). The probability of 
death in ICU increased with age and was slightly larger 
for men than for women (Fig. 3b), falling from a high of 
57.4% in men aged 65 + (49.8% in women aged 65 +) in 
March to 38.3% (31.4%) in May & June. The probability of 
death post-ICU is larger in the 65 + age group than those 
younger; and is similar in men and women (Fig. 3c).
The probabilities of death from each stage of hospital 
care combine to obtain the hospital fatality-risk, aver-
aged over pathways through hospital, as shown in Fig. 4. 
Further summaries of the probabilities of each pathway 
through hospital and lengths of stay by pathway through 
hospital are shown in Additional file 1: Appendix S4.
The median time from hospital admission to either an 
ICU admission or a discharge increased with age, did not 
substantially differ by sex, and decreased with month of 
admission (Fig. 5, first two columns). The median time to 
ICU admission reduced from around 3 days in February 
to less than a day in June; the median LoS for a patient 
discharged without ICU admission decreased from more 
than 20 days in 65 + year-olds in February to 6 days in the 
same group in June. LoS among patients not admitted 
to ICU who died did not vary much by age or sex, and 
was only substantially larger, but also more uncertain, 
for admissions in February (around 15–25 days) than for 
later admissions (less than 10 days, Fig. 5, 3rd column).
Median LoS in ICU did not differ substantially by sex; 
increased with age among survivors; decreased with 
month from a peak in March among survivors (Fig.  6 
left column); decreased with age; and did not vary sub-
stantially with month for non-survivors, other than a 
decrease in May–June compared to earlier months (Fig. 6 
right column).
Median LoS post-ICU increased with age, was slightly 
longer in women than men, and decreased with month 
of admission, among patients who survived to discharge 
(Fig.  7). The number of deaths observed post-ICU was 
small, so month of admission, age and sex were not 
selected as significant covariates for post-ICU LoS among 
non-survivors.
Care home residence
Being a care home resident aged 65 + was substan-
tially associated with the probabilities of being admit-
ted to ICU (odds ratio 0.251 [0.143–0.439] relative to 
Fig. 6 Summaries of distributions of time from ICU admission to next events
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non-care-home residents) and of dying without ICU 
admission (odds ratio 3.037 [2.698–3.419] relative to 
non-care-home residents), resulting in the predicted 
probabilities shown in Fig.  8a, right-hand two columns. 
Care home residency was less associated with the prob-
ability of survival from an ICU admission (Fig. 8b).
Care home residence among 65 + year-olds was signifi-
cantly associated with LoS (Fig.  9), substantially reduc-
ing both the hospital LoS for non-survivors not admitted 
to ICU (ETR 0.796, [0.736–0.860] relative to non-care-
home residents) and the ICU LoS for survivors (ETR 
0.480 [0.262–0.878] relative to non-care-home residents).
Healthcare workers
Being a healthcare worker aged 45–65 was slightly asso-
ciated with a lower risk of death from hospital without 
ICU, particularly in the earlier months of admission 
(Fig. 10a). It is notable that being a healthcare worker in 
the youngest age group showed little difference in the risk 
of death from hospital without ICU compared to other 
patients. Healthcare workers had a significantly lower 
risk of death from an ICU admission (odds ratio 0.254 
[0.143–0.453] relative to non-healthcare workers), result-
ing in predicted probabilities less than 10% in healthcare 
workers, compared to greater than 10% in other ICU 
patients (Fig. 10b).
Being a healthcare worker shortened the median LoS in 
hospital amongst survivors aged under 65 and not admit-
ted to ICU (Fig. 11, first two columns). Healthcare work-
ers were also significantly associated with a shorter LoS 
post-ICU for survivors aged under 65 (Fig. 11, third col-
umn) and for those aged 65 + (ETR 0.818 [0.702–0.953] 
relative to non-healthcare workers).
Co‑morbidities
Having at least one co-morbidity was significantly 
associated with probabilities of next events among 
65 + year-olds, although with small effect sizes: 
Fig. 7 Summaries of distributions of length of stay in a post-ICU ward, among survivors
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Fig. 8 Predicted probabilities (95% confidence intervals) of moving from a hospital or b ICU to next events (columns), by sex (rows), month 
of admission (x-axis) and care home residency (colours), among patients aged 65 + in large hospitals, with no co-morbidities, and who are not 
healthcare workers
Fig. 9 Estimated length of stay, by care home residence, sex and period of admission, in: a hospital for 65 + year-old women in large hospitals with 
no co-morbidities, who are not healthcare workers, and who die without ICU admission; b ICU for 65 + year-old patients in large hospitals with no 
co-morbidities, who are not healthcare workers, and who survive till a post-ICU stay. Note the small sample sizes and hence uncertain estimate of 
the median times for care home residents: although these are the sample sizes only for the baseline strata of other covariates, the estimates are also 
influenced by the sample sizes in non-baseline strata
(See figure on next page.)
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Fig. 9 (See legend on previous page.)
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reducing the risk of ICU admission, but increasing 
the risk of death, from either a hospital ward or ICU 
(Fig.  12). There was a small but significant association 
of co-morbidity with LoS among survivors not admitted 
to ICU, with 65 + year-old patients with co-morbidities 
having a longer LoS than those with none (ETR 1.120 
[1.071–1.172]). Co-morbidity was also slightly associ-
ated with ICU LoS among non-survivors, with a small 
but just significant effect size (65 + year-old patients 
have a shorter time to death, ETR 0.915 [0.837–1.000] 
relative to patients with no co-morbidities).
Hospital bed capacity
Grosso, Presanis et al. [8] found hospital bed capacity was 
significantly associated with both probabilities and times 
in univariable models. Here the association remained 
when adjusting also for patient characteristics. In fact, 
the effect size on probabilities of next events became 
larger, for those aged 65 + in the multivariably-adjusted 
model: the smallest hospitals have both the lowest risk of 
ICU admission (odds ratio 0.305 [0.254–0.367] relative to 
the largest hospitals) and the lowest risk of death without 
ICU admission (odds ratio 0.547 [0.507–0.590] relative to 
the largest hospitals) for this age group (Fig. 13). The risk 
of death in ICU, for all age groups, was also smaller in 
the smallest hospitals compared to the largest (odds ratio 
0.270 [0.202–0.363] for 65 +). As previously noted [8], 
the lower risks of ICU-related events in smaller hospitals 
may, however, be an artefact of the smaller hospitals hav-
ing less ICU capacity.
Discussion and conclusions
This analysis is one of the first to demonstrate the associ-
ation of key risk factors with hospital burden of COVID-
19 in Regione Lombardia during the first wave, while 
correctly accounting for confounders, censoring and the 
competing risks of different pathways through hospital. 
To our knowledge, similar studies have been conducted 
in England, investigating trends in severe outcomes for 
hospitalised COVID-19 cases [6, 7]. Their findings are 
comparable to ours in terms of direction and magni-
tude of the investigated associations; nevertheless, our 
findings provide important confirmation of these asso-
ciations, particularly given the differences between the 
Italian and the English health systems. We estimated 
a steady decrease in the risks of severe events such as 
ICU admission and mortality. Lengths of stay in hospi-
tal among survivors who are eventually discharged have 
reduced over time. In contrast, there is less evidence 
of any change in the lengths of stay for non-survivors. 
Our hypothesis is that the decreasing risks of severe 
events and lengths of stay by month of admission reflect 
a combination of factors: (1) improvement in clinical 
knowledge, patient management and treatment [17]; (2) 
Fig. 10 Predicted probabilities (95% confidence intervals) of death from either a hospital or b ICU, by age group (columns for ages less than 65), 
sex (rows), month of admission (x-axis) and healthcare worker status (colours), for patients with no co-morbidities in the largest hospitals, who are 
not care home residents
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improvements in the surveillance system, which allowed 
identification of infected individuals earlier in their infec-
tion, resulting in better management of their disease [18]; 
(3) the decrease in infection rates over the months fol-
lowing the introduction of the strict lockdown [19]. The 
implication of these results in terms of specific risk fac-
tors are discussed below.
Consistently with other studies [20], risks of ICU 
admission and fatality increase with age group, pres-
ence of comorbidities, and are generally higher for men 
than for women. Similarly, lengths of stay in hospitals 
increase with age for survivors, but slightly decrease with 
age for non-survivors, although the differences are small 
for non-survivors. This latter finding may be because 
patients who die may be fragile in terms of unobserved 
confounders not already captured by the co-morbidities 
and other covariates, so that younger age does not confer 
any substantial advantage. Sex appears to be only mar-
ginally associated with length of stay.
Although risk of being infected with SARS-CoV-2 
is three-fold higher for healthcare workers than in the 
general population [21], and this group has an elevated 
prevalence of prior infection [22, 23], they appear more 
protected in terms of shorter lengths of stay in ICU 
and hospital, among individuals under 65  years of age; 
and to have overall significantly lower risk of death 
in ICU. Working-age healthcare workers have similar 
hospital-fatality risks to other patients, particularly in 
the 0–45  year-old group, but have lower ICU-fatality 
risks. These findings are consistent with other studies in 
healthcare workers during the MERS epidemic [24, 25]. 
Having easy access to the hospital and clinicians and 
being physically present for long shifts may have been an 
advantage for those that fell ill, allowing early diagnosis, 
close monitoring and timely treatment. Also, we cannot 
rule out that part of the protection may be attributed to 
some sort of empathetic “comrade effect”. Further studies 
are needed to ascertain this protective association.
COVID-19 outbreaks in care homes have been hot-
spots of the pandemic in Lombardia. In April, hospitals 
overwhelmed with in-patients, and required to provide 
more and more beds, were allowed to discharge patients 
still in need of low-intensity care to suitable care homes 
[26]. Debate is ongoing about whether these discharges 
might have increased transmission in this setting, 
although a survey from the Italian National Institute of 
Fig. 11 Summaries of distribution of time from either a hospital ward (columns 1 and 2) or a post-ICU stay (column 3) to discharge, by age group, 
sex, month of admission and healthcare worker status, among patients with no co-morbidities in the largest hospitals, who are not care home 
residents
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Fig. 12 Predicted probabilities (95% confidence intervals) of moving from either a hospital admission or b ICU admission to next events, among 
patients aged 65 + in the largest hospitals, who are neither care home residents nor healthcare workers, by sex (rows), month of admission (x-axis) 
and co-morbidities (colours)
Fig. 13 Predicted probabilities (95% confidence intervals) of moving from hospital admission to next events (rows) for patients aged 65 + with no 
co-morbidities and who are neither care home residents nor healthcare workers, by sex (columns), month of admission (x-axis) and hospital bed 
capacity (colours)
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Health on care homes in Italy highlighted that deaths in 
Lombardia care homes occurred mostly during  16th-31st 
March 2020 [27]. Burton et  al. [28] reported that 4% of 
deaths among care home residents in Scotland occurred 
in hospitals, whereas the European Center for Disease 
Control [29] reported that in Belgium, the correspond-
ing proportion was 28%. We have shown that being a 
care home resident was associated with a significant risk 
of not being admitted to ICU and dying in hospital with-
out going through ICU. The largest effect sizes were seen 
for care home residents in the 65 + age group, who are 
at greater risk of death, and for whom lengths of stay are 
shorter, whether they survive or not. Note that the num-
bers of care home residents observed to be admitted to 
hospital as a confirmed COVID-19 case in the first few 
weeks of the epidemic were small (24 in February, 344 in 
March), and of these, none were admitted to ICU. These 
small sample sizes result in uncertain estimates of the 
probability of ICU admission among care home residents 
in these months (around 3–5% in 65 + year olds, com-
pared to 10–30% in 65 + year old non-care-home resi-
dents), that were therefore influenced by the downward 
trend observed in non-care-home residents (Fig.  8a). 
More care home residents were admitted in April, two 
months after the start of the pandemic, when hospitals 
were already overwhelmed. Our hypothesis is that these 
extremely fragile patients reached the hospital in too 
severe condition to be considered eligible for ICU and 
many also died before being admitted to ICU. A poten-
tial contribution to the elevated risk for care home resi-
dents may be that in the relatively wide 65 + age group, 
care home residents have an older age distribution than 
non-residents. Further studies are needed to investigate 
this sensitive issue.
The multi-state modelling approach employed allows 
comprehensive and simultaneous estimation of all hos-
pital case-severity risks and lengths of stay of interest, 
under some assumptions. The dataset used is relatively 
complete and is a comprehensive census of confirmed 
cases hospitalised during the first wave, so is thought 
to be representative of hospitalised cases in the region. 
We have, however, assumed missingness is ignorable for 
some key covariates and for final outcomes [10] and that 
exclusions (Additional file  1: Appendix S1, Figure S1) 
have not biased results in any way. However, although 
uni- and bi-variable models were not sensitive to the 
ignorable missing outcomes assumption [10], sensitiv-
ity for the multivariable analyses has not been assessed, 
due to computational complexity. A selection bias due 
to only tested and confirmed cases being included in the 
register could in theory be present, since untested and 
undiagnosed cases would more likely have been infected 
in the early part of the first wave when testing was not 
yet widely available. However, such cases were also more 
likely to have been only mildly symptomatic or asympto-
matic, and therefore unlikely to have been hospitalised. 
We thus believe such selection is unlikely to have biased 
our analyses based on the hospitalised subset of cases, 
since the vast majority of hospitalised cases will have 
been tested and confirmed as a case. Risk factors poten-
tially associated with hospital burden and severity that 
were not available in the register of confirmed cases were 
ethnicity, socio-economic deprivation and severity of ill-
ness at hospital admission, so we were not able to assess 
any such association.
Further work is underway to apply a similar multi-state 
model to the subset from the Milano Local Healthcare 
Agency district, where good information is available on 
symptom onset dates, to understand the burden in the 
community, such as the proportion of symptomatic cases 
that are hospitalised or who die in the community, as 
well as the corresponding distributions of times to these 
events. Such an analysis, combined with the within-hos-
pital analysis here, will provide further crucial evidence 
on the burden of COVID-19 in Lombardia, in particular 
the overall symptomatic case-fatality risk.
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